Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
13m
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
FBI: Attacker acted alone
Pulls out of Glastonbury
Pearl Harbor survivor dies
New rules for next Congress
Winter storm warnings
Broccoli recalled
Oldest Olympic champ dies
Homemade bombs in Va.
Hawaii fireworks explosion
Russian gas to Europe halted
Montenegro mass shooting
Quake strikes Lake County
Queens nightclub shooting
Preinaugural rally in DC
‘Dinosaur highway’ tracks
'General Hospital’ actor dies
Puerto Rico power restored
Home searched amid probe
How to watch Quadrantids
Reports 1.1% sales drop
To exit climate alliance
Russian drone strike on Kyiv
Suspect served as soldier
New NC gov. sworn in
Israeli airstrikes in Gaza
Most on-time airlines in ‘24
Italy summons Iran envoy
Launches bid for governor
2025 Pro Bowl rosters
Weekly jobless claims fall
Related topics
Vertex Pharmaceuticals
New York
Korsinsky
Feedback